COMMUNIQUÉS West-GlobeNewswire

Acacia Pharma Group plc Results For The Year Ended 31 December 2018

27/02/2019 - 07:00

Cambridge, UK and Indianapolis, US – 27 February 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Group” or the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and [...]

The rolling submission to FDA for darolutamide in the U.S. completed

27/02/2019 - 06:01

Orion Corporation Press Release Communications 27 February 2019 at 07:00 a.m. EET The rolling submission to FDA for darolutamide in the U.S. completed Orion Corporation and Bayer today announced the completion of the [...]

111 to Announce Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results on March 7, 2019

27/02/2019 - 05:26

SHANGHAI, China, Feb. 26, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its unaudited [...]

Wildflower Debuts to Celebrities at the Oscars

27/02/2019 - 03:53

VANCOUVER, British Columbia, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “Company”) is thrilled to announce that Wildflower products were selected for inclusion in the 2019 [...]

Ultragenyx Announces Pricing of Public Offering of Common Stock

27/02/2019 - 01:13

NOVATO, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, [...]

Adamis Provides Regulatory Update on Sublingual Tadalafil

27/02/2019 - 00:54

SAN DIEGO, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has received a Refusal to File letter from the United States Food and Drug Administration (FDA) [...]

ASLAN Pharmaceuticals to Partner With BioGenetics on Commercialisation of Varlitinib in South Korea

26/02/2019 - 23:35

SINGAPORE, Feb. 27, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets, and BioGenetics [...]

Precision Therapeutics Inc. Announces Proposed Public Offering of Securities

26/02/2019 - 23:15

MINNEAPOLIS, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a proposed public offering of its common stock and warrants to purchase common [...]

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

26/02/2019 - 23:00

Phase 3 Geographic Atrophy Program Expected to Restart By or In Q2 2019 Phase 3 Trial of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria Expected to be Fully Enrolled by End of Q2 2019 Cash Position of $176.3 [...]

Supernus Announces Record Full Year 2018 Financial Results

26/02/2019 - 22:56

Fourth quarter 2018 total revenue of $115.9 million, a 31% increase over 2017, and fourth quarter 2018 net product sales of $113.5 million, a 32% increase over 2017. Fourth quarter 2018 operating earnings of $39.9 [...]

Veloxis to Host Conference Call Following Release of 2018 Annual Report

26/02/2019 - 22:44

Investor News no. 01/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 26 February 2019 Veloxis to Host Conference Call Following Release of 2018 Annual Report As previously announced, Veloxis Pharmaceuticals A/S ( [...]

Flexion Therapeutics to Present at the 40th Annual Raymond James Institutional Investors Conference

26/02/2019 - 22:30

BURLINGTON, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it will be presenting at the 40 th Annual Raymond James Institutional Investors Conference in Orlando, [...]

Harvard Bioscience Subsidiary Data Sciences International to Participate at SOT 2019 With Presentation and Exhibit

26/02/2019 - 22:30

Company To Sponsor Session on Novel Approaches for Respiratory Measurement, Showcase Portfolio of Instrumentation Products and Solutions and Present Data HOLLISTON, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Data Sciences [...]

Atrion Reports Results for Fourth Quarter and Full Year 2018

26/02/2019 - 22:30

ALLEN, Texas, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2018 revenues were $34.9 million compared to $34.0 million in the same period of 2017, net [...]

BOAZ to Honour Human Potential with Handcrafted Art Installation at HempFest Edmonton

26/02/2019 - 22:20

The BOAZ team celebrates craft and growth as brand launches new identity EDMONTON, Alberta, Feb. 26, 2019 (GLOBE NEWSWIRE) -- BOAZ Pharmaceuticals Inc. (BOAZ) received its license for cultivation in June 2018, and the [...]

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results

26/02/2019 - 22:15

MINNEAPOLIS, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Julie Bornstein and Tracey D. Brown Join Board of Directors of WW – the new Weight Watchers

26/02/2019 - 22:10

NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- WW (NASDAQ: WTW) – the new Weight Watchers – today announced two board appointments: Julie Bornstein, Chief Executive Officer of a new venture-backed company she founded and [...]

Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus Nephritis

26/02/2019 - 22:07

Clinical trial evaluating EQ001 for the treatment of refractory lupus nephritis to commence in 2H 2019 Ongoing EQ001 development programs in acute graft-versus-host disease and severe asthma remain on-track Company to [...]

Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results

26/02/2019 - 22:05

ANN ARBOR, Mich., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today reported [...]